| Subgroups analysis of arteriosclerosis |
No. of trials |
Hazard ratio
(95% CI) |
P-subgroup
difference |
| Sample size |
>200 |
3 |
1.67 (0.90, 3.09) |
0.40 |
| <200 |
2 |
2.64 (1.11, 6.29) |
| Follow-up |
>7 years |
1 |
2.90 (1.07, 7.84) |
0.31 |
| < 7 years |
4 |
1.63 (0.99, 2.69) |
| Endpoint |
ESRD
Renal failure |
3 |
2.43 (1.13, 5.20) |
0.34 |
| 2 |
1.51 (0.84, 2.72) |
| Adjustment |
Univariate
Multivariate |
0 |
- |
- |
| 5 |
1.83 (1.17, 2.86) |
| Baseline eGFR |
<80 ml/min per 1.73 m2
>80 ml/min per 1.73 m2 |
2 |
1.54 (0.63, 3.78) |
0.53 |
| 3 |
2.23 (1.06, 4.73) |
| Percentage of nephrotic syndrome |
100% |
1 |
1.46 (0.78, 2.73) |
0.31 |
| <100% |
4 |
2.32 (1.23, 4.37) |
| Percentage of immunosuppression |
>80% |
3 |
1.79 (1.08, 2.97) |
0.66 |
| <80% |
2 |
2.60 (0.52, 13.03) |
| Country |
North American/Europe |
2 |
1.54 (0.63, 3.78) |
0.53 |
| Asia |
3 |
2.23 (1.06, 4.73) |
|
